TEAM LEADER
PRINCIPAL INVESTIGATORS
STAFF
Roger Appelqvist | Henrik Lindberg | Henriett Kovácsné Oskolás | Zsolt Horvath |
---|---|---|---|
Project Manager, PhD | Biobank Manager, PhD | Head of Biobank | IT Manager |
Melinda Rezeli | Lázaro H. Betancourt Nuñez | Jeovanis Gil Valdés | Aniel Sánchez Puente |
---|---|---|---|
Senior Researcher, PhD | Senior Researcher, PhD | Senior Researcher, PhD | Senior Researcher, PhD |
Elisabet Wieslander | Matilda Marko-Varga | Ethan Gerendas | |
---|---|---|---|
Senior Researcher, PhD | Lab Technician | Social media coordinator |
PHD STUDENTS
Beáta Szeitz | Leticia Szadai | ||
---|---|---|---|
MSc. Analytical Chemistry | Clinical resident, MD |
POST DOCS
Indira Pla Parada | Magdalena Kuras | Jessica de Siqueira Guedes | Natália Almeida |
---|---|---|---|
Bioinformatician, PhD | Biomedicine PhD | Chemistry PhD | Chemistry PhD |
Nicole Woldmar | |||
---|---|---|---|
Biochemistry PhD |
RESEARCH ASSOCIATES
AFFILIATED PROFESSORS
Toshihide Nishimura | Balazs Döme | Ho Jeong Kwon | A. Marcell Szasz |
---|---|---|---|
Professor, MD | Professor, MD | Professor | Associate Professor, MD |
Quotes from some of our team members:
“Of course the most important goal is to help the patients survive the cancer. That’s the final goal, and if you can even be a small part in reaching that goal it is very important.” – Istvan Nemth
“I think that we focus on the patient. For instance, mass spec is such a technical thing, but all the things that we have to work with here are just tools to answer biological questions so we can help the patient. ” – Magdalena Kuras
“I really hope that we will be able to get developments within our center to develop a treatment or be part of a treatment that can be implemented for patient use. That is the absolute goal.” – Gyorgy Marko-Varga
“This is a big effort. So if we a big step forward in the fight against cancer, whether it is diagnosis or treatment. Through cooperation as well, that is going to be huge.” – Lazaro Betancourt
“We are trying to get scientists working together in a different way. Of course, there are a lot of scientists working together today, but there are also a lot of scientists who do not cooperate and keep it for themselves. So it’s a new way for us to get the science together.”- Roger Appleqvist
Our team strength:
Within the European Cancer Moonshot research team, our strength lies in the rich tapestry of expertise drawn from 10 different countries and 4 continents. Our team spans a wide age range, encompassing young students eager to contribute their fresh perspectives and skills, to more seasoned professionals with extensive experiences hailing from academia, the pharmaceutical industry, start-up companies, and the healthcare sector.
Our collective proficiency extends across various facets of the medical field, reflecting a comprehensive understanding of cancer research. Originating from diverse backgrounds, our team members contribute specialized skills in patient care, including clinical handling, surgery, and pathology within the hospital setting. We also possess deep insights into central laboratory clinical chemistry, allowing us to delve into intricate biochemical aspects of our research.
Moreover, our team is enriched by individuals well-versed in radiology, further broadening our capabilities in comprehensively addressing the complexities of cancer research. This collaborative approach, fueled by a broad spectrum of skills and experiences, ensures a holistic perspective in our research endeavors. From patient diagnosis and treatment to the intricate analysis of clinical data and laboratory findings, our diverse team is well-equipped to make significant contributions to the field of cancer research. Our specialties lies within molecular pathology, and especially clinical protein science that provides the functional link to disease.